Liquid Biopsy Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
The study predicts the short term and long term trends that can shape up the future of the Liquid Biopsy market including the COVID-19 pandemic implications for Liquid Biopsys industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.
The Liquid Biopsy market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Liquid Biopsy Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Liquid Biopsy market forecast and Liquid Biopsy market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023- 2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Liquid Biopsy market opportunities, underlying market factors, demographic and economic factors, market developments and others.
Liquid Biopsy industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Liquid Biopsy market share in developed countries.
Scope of the research-
Liquid Biopsy Market Value Outlook to 202 Outlook By Circulating Biomarker
Extracellular Vesicles (Evs)
Circulating Tumor Cells
Circulating Tumor DNA (CTDNA)
Cell-Free DNA
Other Circulating Biomarkers
Liquid Biopsy Market is analyzed and forecast over the outlook period from 2023 to 2030 By Product including and Service
Instruments
Assay Kits
Services
Liquid Biopsy Market is analyzed and forecast over the outlook period from 2023 to 2030 By application including
Non-Cancer Applications
Cancer Applications
Lung Cancer
Liver Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other Cancers
Liquid Biopsy Market Value Outlook to 202 Outlook By Clinical Application
Treatment Monitoring
Recurrence Monitoring
Early Cancer Screening
Therapy Selection
Liquid Biopsy Market Value Outlook to 202 Outlook Market is analyzed and forecast over the outlook period from 2023 to 2030 by technology including
Multi-gene-parallel Analysis (NGS)
Single Gene Analysis (PCR Microarrays)
Liquid Biopsy Market Value Outlook to 202 Outlook Market is analyzed and forecast over the outlook period from 2023 to 2030 by End User including
Hospitals and Physician Laboratories
Academic and Research Centers
Reference Laboratories
Other End Users
Top Companies Operating in Liquid Biopsy market include- Bio-Rad Laboratories, Inc. , Biocept, Inc. , Genomic Health, Inc. , Menarini-Silicon Biosystems , Myriad Genetics, Inc , Qiagen N.V. , Raindance Technologies, Inc , Roche Diagnostics , 150 Thermo Fisher Scientific Inc. , 151 Trovagene, Inc. ,
Recent Industry Developments
1Appendix
1OGAnalysis Expertise
1Sources and Methodology
1Contacts
The Liquid Biopsy market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Liquid Biopsy Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Liquid Biopsy market forecast and Liquid Biopsy market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023- 2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Liquid Biopsy market opportunities, underlying market factors, demographic and economic factors, market developments and others.
Liquid Biopsy industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Liquid Biopsy market share in developed countries.
Scope of the research-
Liquid Biopsy Market Value Outlook to 202 Outlook By Circulating Biomarker
Extracellular Vesicles (Evs)
Circulating Tumor Cells
Circulating Tumor DNA (CTDNA)
Cell-Free DNA
Other Circulating Biomarkers
Liquid Biopsy Market is analyzed and forecast over the outlook period from 2023 to 2030 By Product including and Service
Instruments
Assay Kits
Services
Liquid Biopsy Market is analyzed and forecast over the outlook period from 2023 to 2030 By application including
Non-Cancer Applications
Cancer Applications
Lung Cancer
Liver Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other Cancers
Liquid Biopsy Market Value Outlook to 202 Outlook By Clinical Application
Treatment Monitoring
Recurrence Monitoring
Early Cancer Screening
Therapy Selection
Liquid Biopsy Market Value Outlook to 202 Outlook Market is analyzed and forecast over the outlook period from 2023 to 2030 by technology including
Multi-gene-parallel Analysis (NGS)
Single Gene Analysis (PCR Microarrays)
Liquid Biopsy Market Value Outlook to 202 Outlook Market is analyzed and forecast over the outlook period from 2023 to 2030 by End User including
Hospitals and Physician Laboratories
Academic and Research Centers
Reference Laboratories
Other End Users
Top Companies Operating in Liquid Biopsy market include- Bio-Rad Laboratories, Inc. , Biocept, Inc. , Genomic Health, Inc. , Menarini-Silicon Biosystems , Myriad Genetics, Inc , Qiagen N.V. , Raindance Technologies, Inc , Roche Diagnostics , 150 Thermo Fisher Scientific Inc. , 151 Trovagene, Inc. ,
Recent Industry Developments
1Appendix
1OGAnalysis Expertise
1Sources and Methodology
1Contacts
1. TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2. EXECUTIVE SUMMARY
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Liquid Biopsy Market- Key Findings, 2022
3. STRATEGIC IMPERATIVES ON GLOBAL LIQUID BIOPSY MARKET
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Liquid Biopsy Companies
4.LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY CIRCULATING BIOMARKER
4.1 Extracellular Vesicles (Evs)
4.2 Circulating Tumor Cells
4.3 Circulating Tumor DNA (CTDNA)
4.4 Cell-Free DNA
4.5 Other Circulating Biomarkers
5. LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY PRODUCT AND SERVICE
5.1 Instruments
5.2 Assay Kits
5.3 Services
6. LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY APPLICATION
6.1 Non-Cancer Applications
6.2 Cancer Applications
6.2.1 Lung Cancer
6.2.2 Liver Cancer
6.2.3 Breast Cancer
6.2.4 Prostate Cancer
6.2.5 Colorectal Cancer
6.2.6 Other Cancers
7. LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY CLINICAL APPLICATION
7.1 Treatment Monitoring
7.2 Recurrence Monitoring
7.3 Early Cancer Screening
7.4 Therapy Selection
8. LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY TECHNOLOGY
8.1 Multi-gene-parallel Analysis (NGS)
8.2 Single Gene Analysis (PCR Microarrays)
9. LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY END USER
9.1 Hospitals and Physician Laboratories
9.2 Academic and Research Centers
9.3 Reference Laboratories
9.4 Other End Users
10 ASIA PACIFIC LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030
10.1 Leading Liquid Biopsy Types contributing to Asia Pacific market
10.2 Top Applications contributing to Asia Pacific Liquid Biopsy
10.3 Top countries contributing to Asia Pacific Liquid Biopsy
11 EUROPE LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030
11.1 Leading Liquid Biopsy Types contributing to Europe market
11.2 Top Applications contributing to Europe Liquid Biopsy
11.3 Top countries contributing to Europe Liquid Biopsy
12 NORTH AMERICA LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030
12.1 Leading Liquid Biopsy Types contributing to North America market
12.2 Top Applications contributing to North America Liquid Biopsy
12.3 Top countries contributing to North America Liquid Biopsy
13 SOUTH AND CENTRAL AMERICA LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030
13.1 Leading Liquid Biopsy Types contributing to South and Central America market
13.2 Top Applications contributing to South and Central America Liquid Biopsy
13.3 Top countries contributing to South and Central America Liquid Biopsy
14 MIDDLE EAST AFRICA LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030
14.1 Leading Liquid Biopsy Types contributing to Middle East Africa market
14.2 Top Applications contributing to Middle East Africa Liquid Biopsy
14.3 Top countries contributing to Middle East Africa Liquid Biopsy
15 BUSINESS PROFILES OF LEADING COMPANIES
15.1 Business Description, SWOT and Financial Analysis of Companies in Liquid Biopsy market
15.2 Bio-Rad Laboratories, Inc.
15.3 Biocept, Inc.
15.4 Genomic Health, Inc.
15.5 Menarini-Silicon Biosystems
15.6 Myriad Genetics, Inc
15.7 Qiagen N.V.
15.8 Raindance Technologies, Inc
15.9 Roche Diagnostics
15.10 Thermo Fisher Scientific Inc.
15.11 Trovagene, Inc.
16 RECENT INDUSTRY DEVELOPMENTS
17 APPENDIX
17.1 OGAnalysis Expertise
17.2 Sources and Methodology
17.3 Contacts
1.1 List of Tables
1.2 List of Figures
2. EXECUTIVE SUMMARY
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Liquid Biopsy Market- Key Findings, 2022
3. STRATEGIC IMPERATIVES ON GLOBAL LIQUID BIOPSY MARKET
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Liquid Biopsy Companies
4.LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY CIRCULATING BIOMARKER
4.1 Extracellular Vesicles (Evs)
4.2 Circulating Tumor Cells
4.3 Circulating Tumor DNA (CTDNA)
4.4 Cell-Free DNA
4.5 Other Circulating Biomarkers
5. LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY PRODUCT AND SERVICE
5.1 Instruments
5.2 Assay Kits
5.3 Services
6. LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY APPLICATION
6.1 Non-Cancer Applications
6.2 Cancer Applications
6.2.1 Lung Cancer
6.2.2 Liver Cancer
6.2.3 Breast Cancer
6.2.4 Prostate Cancer
6.2.5 Colorectal Cancer
6.2.6 Other Cancers
7. LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY CLINICAL APPLICATION
7.1 Treatment Monitoring
7.2 Recurrence Monitoring
7.3 Early Cancer Screening
7.4 Therapy Selection
8. LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY TECHNOLOGY
8.1 Multi-gene-parallel Analysis (NGS)
8.2 Single Gene Analysis (PCR Microarrays)
9. LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY END USER
9.1 Hospitals and Physician Laboratories
9.2 Academic and Research Centers
9.3 Reference Laboratories
9.4 Other End Users
10 ASIA PACIFIC LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030
10.1 Leading Liquid Biopsy Types contributing to Asia Pacific market
10.2 Top Applications contributing to Asia Pacific Liquid Biopsy
10.3 Top countries contributing to Asia Pacific Liquid Biopsy
11 EUROPE LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030
11.1 Leading Liquid Biopsy Types contributing to Europe market
11.2 Top Applications contributing to Europe Liquid Biopsy
11.3 Top countries contributing to Europe Liquid Biopsy
12 NORTH AMERICA LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030
12.1 Leading Liquid Biopsy Types contributing to North America market
12.2 Top Applications contributing to North America Liquid Biopsy
12.3 Top countries contributing to North America Liquid Biopsy
13 SOUTH AND CENTRAL AMERICA LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030
13.1 Leading Liquid Biopsy Types contributing to South and Central America market
13.2 Top Applications contributing to South and Central America Liquid Biopsy
13.3 Top countries contributing to South and Central America Liquid Biopsy
14 MIDDLE EAST AFRICA LIQUID BIOPSY MARKET VALUE OUTLOOK TO 2030
14.1 Leading Liquid Biopsy Types contributing to Middle East Africa market
14.2 Top Applications contributing to Middle East Africa Liquid Biopsy
14.3 Top countries contributing to Middle East Africa Liquid Biopsy
15 BUSINESS PROFILES OF LEADING COMPANIES
15.1 Business Description, SWOT and Financial Analysis of Companies in Liquid Biopsy market
15.2 Bio-Rad Laboratories, Inc.
15.3 Biocept, Inc.
15.4 Genomic Health, Inc.
15.5 Menarini-Silicon Biosystems
15.6 Myriad Genetics, Inc
15.7 Qiagen N.V.
15.8 Raindance Technologies, Inc
15.9 Roche Diagnostics
15.10 Thermo Fisher Scientific Inc.
15.11 Trovagene, Inc.
16 RECENT INDUSTRY DEVELOPMENTS
17 APPENDIX
17.1 OGAnalysis Expertise
17.2 Sources and Methodology
17.3 Contacts
